Market Analysis and Insights: Global Microbial Identification Market
Microbial identification is the process of identifying harmful bacteria and fungi that may contaminate raw materials, manufacturing facilities and branded products. Accurate and definitive microbial identification is critical for disease diagnosis and treatment of infections. Bacterial identification is widely used across manufacturing facilities, clinical settings and environmental studies. In this report our statistical data is restricted to the monitoring equipment.
Due to the COVID-19 pandemic, the global Microbial Identification market size is estimated to be worth US$ 314.6 million in 2022 and is forecast to a readjusted size of US$ 396.4 million by 2029 with a CAGR of 3.3% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Fully Automatic Type accounting for % of the Microbial Identification global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospital segment is altered to an % CAGR throughout this forecast period.
The key players of global Microbial Identification include Biomérieux Sa, Siemens Healthcare, Becton, Dickinson and Company, Biolog Inc, Shimadzu Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., MIDI Inc., Qiagen N.V., Charles River Laboratories Inc., Tiandiren Bio-tech, Hengxing Tech, Hangzhou Binhe Microorgan, Bioyong Tech, Scenker and Huizhou Sunshine Bio, etc.
Europe is the largest consumption place, with a consumption market share nearly 36%. Following Europe, North America is the second largest consumption place with the consumption market share of 34%.
Global Microbial Identification Scope and Market Size
The global Microbial Identification market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Microbial Identification market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Fully Automatic Type
Semi Automatic Type
Segment by Application
Hospital
Inspection Agency
Research Institutions
Other
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Biomérieux Sa
Siemens Healthcare
Becton, Dickinson and Company
Biolog Inc
Shimadzu Corporation
Bruker Corporation
Thermo Fisher Scientific, Inc.
MIDI Inc.
Qiagen N.V.
Charles River Laboratories Inc.
Tiandiren Bio-tech
Hengxing Tech
Hangzhou Binhe Microorgan
Bioyong Tech
Scenker
Huizhou Sunshine Bio
Microbial identification is the process of identifying harmful bacteria and fungi that may contaminate raw materials, manufacturing facilities and branded products. Accurate and definitive microbial identification is critical for disease diagnosis and treatment of infections. Bacterial identification is widely used across manufacturing facilities, clinical settings and environmental studies. In this report our statistical data is restricted to the monitoring equipment.
Due to the COVID-19 pandemic, the global Microbial Identification market size is estimated to be worth US$ 314.6 million in 2022 and is forecast to a readjusted size of US$ 396.4 million by 2029 with a CAGR of 3.3% during the forecast period 2023-2029. Fully considering the economic change by this health crisis, Fully Automatic Type accounting for % of the Microbial Identification global market in 2022, is projected to value US$ million by 2029, growing at a revised % CAGR from 2023 to 2029. While Hospital segment is altered to an % CAGR throughout this forecast period.
The key players of global Microbial Identification include Biomérieux Sa, Siemens Healthcare, Becton, Dickinson and Company, Biolog Inc, Shimadzu Corporation, Bruker Corporation, Thermo Fisher Scientific, Inc., MIDI Inc., Qiagen N.V., Charles River Laboratories Inc., Tiandiren Bio-tech, Hengxing Tech, Hangzhou Binhe Microorgan, Bioyong Tech, Scenker and Huizhou Sunshine Bio, etc.
Europe is the largest consumption place, with a consumption market share nearly 36%. Following Europe, North America is the second largest consumption place with the consumption market share of 34%.
Global Microbial Identification Scope and Market Size
The global Microbial Identification market is segmented by company, region (country), type and application. Players, stakeholders, and other participants in the global Microbial Identification market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), type and application for the period 2018-2029.
Segment by Type
Fully Automatic Type
Semi Automatic Type
Segment by Application
Hospital
Inspection Agency
Research Institutions
Other
By Region
United States
Europe
China
Japan
Southeast Asia
India
Other Regions
By Company
Biomérieux Sa
Siemens Healthcare
Becton, Dickinson and Company
Biolog Inc
Shimadzu Corporation
Bruker Corporation
Thermo Fisher Scientific, Inc.
MIDI Inc.
Qiagen N.V.
Charles River Laboratories Inc.
Tiandiren Bio-tech
Hengxing Tech
Hangzhou Binhe Microorgan
Bioyong Tech
Scenker
Huizhou Sunshine Bio
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
Pre-order Enquiry
Download Free Sample








